A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.
Clinical trial NCT03645434 · COMPLETED
Trial details
- NCT number
- NCT03645434
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2019-08-07
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.